Comparison of Different Gonadotropins in PCOS Patients undergoing in vitro Fertilization: A Randomized Controlled Trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IPR-16008355

Enrollment

Unknown

Registered

2016-04-24

Start date

2015-08-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

rFSH group:rFSH as gondadotropin

HP-HMG group:HP-HMG as gondadotropin

Eligibility

Sex/Gender

Female

Age

20 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1. women diagnosed with PCOS; 2. the first IVF cycle; 3. aged 20-37 years; 4. basal FSH<=12U/L.

Exclusion criteria

Exclusion criteria: 1) women with history of ovarian sugery; 2) women who is allergic to FSH or LH; 3) ovary unclear in hysterosalpingography; 4) women with other endocrinal disease; 5) women with severe endometriosis; 6) women with hypothalamic or pituitary tumors; 7) women with malignant neoplasm in ovary, uterus or breast; 8) women participant other clinical trials in 3 months before inception of this study; 9) women with drug or alcohol dependence; 10) infection or other contraindications of IVF/ICSI-ET.

Design outcomes

Primary

Measure	Time frame
number of oocyte retrieved;	—

Countries

China

Contacts

Public ContactYang Dongzi

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

yangdz@mail.sysu.edu.cn+86 13922272513

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026